Scivita Medical Technology Co., Ltd., a Hong Kong-based manufacturer of endoscopy products, received nearly RMB 0.4 billion in Series B funding.
The backers included new investors such as Hudson Bay Capital Management and Prime Capital, as well as existing shareholders such as GL Ventures, Lilly Asia Ventures and Matrix Partners China.
The company intends to use the funds for research and development, capacity expansion and domestic and international commercialization of innovative products in endoscopy and related fields.
Scivita Medical offers products such as 3D viewing system, 4K UHD camera system, 4K-3D camera system, 4K sinoscope, 4K arthroscope, Hystero disposable videoscope, Urology videoscope with single-use, single-use bronchial videoscope, etc. In the future, the company will continue to launch new products while promoting the simultaneous certification of related products in China, the United States, Japan, Europe and other countries and regions, and will continue to promote the products in the world market.
Since its inception, Scivita Medical has made globalization an important strategy and set up R&D centers in Suzhou, China and Tokyo, Japan to simultaneously promote global R&D, patent application, registration and marketing of its products, and aims to build a global platform for innovative products in endoscopy and related fields.